efavirenz has been researched along with Necrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lugongolo, MY; Maaza, M; Manoto, SL; Mthunzi-Kufa, P; Ombinda-Lemboumba, S | 1 |
| Chen, H; Christ, DD; Davies, MH; Gan, LS; Gemzik, B; Gerson, RJ; Haley, PJ; Krahn, DF; Markwalder, JA; Meunier, PC; Miwa, GT; Mutlib, AE; Robertson, RT; Seitz, SP | 1 |
2 other study(ies) available for efavirenz and Necrosis
| Article | Year |
|---|---|
The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells.
Topics: Alkynes; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Low-Level Light Therapy; Necrosis | 2021 |
The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats.
Topics: Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Enzyme Inhibitors; Epithelial Cells; Gas Chromatography-Mass Spectrometry; Glutathione; Haplorhini; Humans; Isoxazoles; Kidney Diseases; Kidney Tubules; Male; Necrosis; Oxazines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Species Specificity | 2000 |